Logo image of LH

LABCORP HOLDINGS INC (LH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LH - US5049221055 - Common Stock

258.39 USD
-3.09 (-1.18%)
Last: 12/5/2025, 8:04:00 PM
258.39 USD
0 (0%)
After Hours: 12/5/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, LH scores 5 out of 10 in our fundamental rating. LH was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of LH get a neutral evaluation. Nothing too spectacular is happening here. LH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

LH had positive earnings in the past year.
LH had a positive operating cash flow in the past year.
Each year in the past 5 years LH has been profitable.
In the past 5 years LH always reported a positive cash flow from operatings.
LH Yearly Net Income VS EBIT VS OCF VS FCFLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

LH has a better Return On Assets (4.68%) than 76.24% of its industry peers.
LH has a Return On Equity of 9.83%. This is in the better half of the industry: LH outperforms 72.28% of its industry peers.
LH has a Return On Invested Capital of 6.32%. This is in the better half of the industry: LH outperforms 64.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LH is below the industry average of 9.22%.
The last Return On Invested Capital (6.32%) for LH is above the 3 year average (6.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROIC 6.32%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
LH Yearly ROA, ROE, ROICLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

LH has a Profit Margin of 6.21%. This is amongst the best in the industry. LH outperforms 82.18% of its industry peers.
In the last couple of years the Profit Margin of LH has declined.
LH's Operating Margin of 9.92% is fine compared to the rest of the industry. LH outperforms 77.23% of its industry peers.
LH's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 28.45%, LH perfoms like the industry average, outperforming 55.45% of the companies in the same industry.
In the last couple of years the Gross Margin of LH has remained more or less at the same level.
Industry RankSector Rank
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
LH Yearly Profit, Operating, Gross MarginsLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LH is destroying value.
The number of shares outstanding for LH has been reduced compared to 1 year ago.
Compared to 5 years ago, LH has less shares outstanding
LH has a worse debt/assets ratio than last year.
LH Yearly Shares OutstandingLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LH Yearly Total Debt VS Total AssetsLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

LH has an Altman-Z score of 3.12. This indicates that LH is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.12, LH is doing good in the industry, outperforming 66.34% of the companies in the same industry.
The Debt to FCF ratio of LH is 4.09, which is a neutral value as it means it would take LH, 4.09 years of fcf income to pay off all of its debts.
LH has a better Debt to FCF ratio (4.09) than 70.30% of its industry peers.
LH has a Debt/Equity ratio of 0.59. This is a neutral value indicating LH is somewhat dependend on debt financing.
LH's Debt to Equity ratio of 0.59 is in line compared to the rest of the industry. LH outperforms 57.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Altman-Z 3.12
ROIC/WACC0.78
WACC8.15%
LH Yearly LT Debt VS Equity VS FCFLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

LH has a Current Ratio of 1.55. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of LH (1.55) is comparable to the rest of the industry.
LH has a Quick Ratio of 1.35. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
LH's Quick ratio of 1.35 is in line compared to the rest of the industry. LH outperforms 54.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.35
LH Yearly Current Assets VS Current LiabilitesLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.71% over the past year.
Measured over the past 5 years, LH shows a small growth in Earnings Per Share. The EPS has been growing by 5.20% on average per year.
Looking at the last year, LH shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
The Revenue has been growing slightly by 2.40% on average over the past years.
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%

3.2 Future

LH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.98% yearly.
Based on estimates for the next years, LH will show a small growth in Revenue. The Revenue will grow by 4.07% on average per year.
EPS Next Y15.41%
EPS Next 2Y11.3%
EPS Next 3Y10.56%
EPS Next 5Y7.98%
Revenue Next Year7.86%
Revenue Next 2Y6.15%
Revenue Next 3Y5.76%
Revenue Next 5Y4.07%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LH Yearly Revenue VS EstimatesLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
LH Yearly EPS VS EstimatesLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

6

4. Valuation

4.1 Price/Earnings Ratio

LH is valuated correctly with a Price/Earnings ratio of 16.33.
79.21% of the companies in the same industry are more expensive than LH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LH to the average of the S&P500 Index (26.46), we can say LH is valued slightly cheaper.
A Price/Forward Earnings ratio of 14.32 indicates a correct valuation of LH.
Based on the Price/Forward Earnings ratio, LH is valued a bit cheaper than 79.21% of the companies in the same industry.
LH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.10.
Industry RankSector Rank
PE 16.33
Fwd PE 14.32
LH Price Earnings VS Forward Price EarningsLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

LH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LH is cheaper than 60.40% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LH indicates a somewhat cheap valuation: LH is cheaper than 73.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.51
EV/EBITDA 14.02
LH Per share dataLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of LH may justify a higher PE ratio.
PEG (NY)1.06
PEG (5Y)3.14
EPS Next 2Y11.3%
EPS Next 3Y10.56%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.07%, LH has a reasonable but not impressive dividend return.
LH's Dividend Yield is rather good when compared to the industry average which is at 2.47. LH pays more dividend than 85.15% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, LH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.07%

5.2 History

The dividend of LH is nicely growing with an annual growth rate of 96.38%!
LH has been paying a dividend for over 5 years, so it has already some track record.
The dividend of LH decreased in the last 3 years.
Dividend Growth(5Y)96.38%
Div Incr Years2
Div Non Decr Years2
LH Yearly Dividends per shareLH Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 1 2 3

5.3 Sustainability

LH pays out 28.24% of its income as dividend. This is a sustainable payout ratio.
The dividend of LH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.24%
EPS Next 2Y11.3%
EPS Next 3Y10.56%
LH Yearly Income VS Free CF VS DividendLH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
LH Dividend Payout.LH Dividend Payout, showing the Payout Ratio.LH Dividend Payout.PayoutRetained Earnings

LABCORP HOLDINGS INC

NYSE:LH (12/5/2025, 8:04:00 PM)

After market: 258.39 0 (0%)

258.39

-3.09 (-1.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-04 2026-02-04
Inst Owners100.29%
Inst Owner Change-2.19%
Ins Owners0.33%
Ins Owner Change-2.8%
Market Cap21.42B
Revenue(TTM)13.77B
Net Income(TTM)855.20M
Analysts83.45
Price Target305.58 (18.26%)
Short Float %3.89%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 1.07%
Yearly Dividend2.91
Dividend Growth(5Y)96.38%
DP28.24%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-26 2025-11-26 (0.72)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.25%
Min EPS beat(2)-1.84%
Max EPS beat(2)1.34%
EPS beat(4)1
Avg EPS beat(4)-0.49%
Min EPS beat(4)-1.84%
Max EPS beat(4)1.34%
EPS beat(8)3
Avg EPS beat(8)-0.27%
EPS beat(12)4
Avg EPS beat(12)-0.63%
EPS beat(16)6
Avg EPS beat(16)0.3%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-2.8%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-2.81%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-2.35%
Revenue beat(12)0
Avg Revenue beat(12)-5.86%
Revenue beat(16)0
Avg Revenue beat(16)-13.64%
PT rev (1m)-0.47%
PT rev (3m)1.82%
EPS NQ rev (1m)-0.82%
EPS NQ rev (3m)-0.9%
EPS NY rev (1m)0.06%
EPS NY rev (3m)0.13%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 16.33
Fwd PE 14.32
P/S 1.56
P/FCF 15.51
P/OCF 11.88
P/B 2.46
P/tB N/A
EV/EBITDA 14.02
EPS(TTM)15.82
EY6.12%
EPS(NY)18.05
Fwd EY6.99%
FCF(TTM)16.66
FCFY6.45%
OCF(TTM)21.76
OCFY8.42%
SpS166.05
BVpS104.91
TBVpS-18.78
PEG (NY)1.06
PEG (5Y)3.14
Graham Number193.24
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROCE 8.73%
ROIC 6.32%
ROICexc 6.57%
ROICexgc 20.66%
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
FCFM 10.03%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
ROICexc(3y)6.66%
ROICexc(5y)9.53%
ROICexgc(3y)24.5%
ROICexgc(5y)35.7%
ROCE(3y)8.72%
ROCE(5y)12.25%
ROICexgc growth 3Y-23.52%
ROICexgc growth 5Y-8.03%
ROICexc growth 3Y-23.85%
ROICexc growth 5Y-3.15%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
F-Score9
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Debt/EBITDA 2.7
Cap/Depr 77.99%
Cap/Sales 3.07%
Interest Coverage 5.52
Cash Conversion 94.58%
Profit Quality 161.46%
Current Ratio 1.55
Quick Ratio 1.35
Altman-Z 3.12
F-Score9
WACC8.15%
ROIC/WACC0.78
Cap/Depr(3y)76.91%
Cap/Depr(5y)70.72%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.56%
Profit Quality(3y)157.09%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
EPS Next Y15.41%
EPS Next 2Y11.3%
EPS Next 3Y10.56%
EPS Next 5Y7.98%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%
Revenue Next Year7.86%
Revenue Next 2Y6.15%
Revenue Next 3Y5.76%
Revenue Next 5Y4.07%
EBIT growth 1Y20.09%
EBIT growth 3Y-28.19%
EBIT growth 5Y-5.19%
EBIT Next Year32.28%
EBIT Next 3Y14.33%
EBIT Next 5Y12.85%
FCF growth 1Y38.44%
FCF growth 3Y-25.49%
FCF growth 5Y0.97%
OCF growth 1Y28.67%
OCF growth 3Y-20.11%
OCF growth 5Y1.88%

LABCORP HOLDINGS INC / LH FAQ

Can you provide the ChartMill fundamental rating for LABCORP HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to LH.


What is the valuation status of LABCORP HOLDINGS INC (LH) stock?

ChartMill assigns a valuation rating of 6 / 10 to LABCORP HOLDINGS INC (LH). This can be considered as Fairly Valued.


What is the profitability of LH stock?

LABCORP HOLDINGS INC (LH) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for LH stock?

The Price/Earnings (PE) ratio for LABCORP HOLDINGS INC (LH) is 16.33 and the Price/Book (PB) ratio is 2.46.


What is the financial health of LABCORP HOLDINGS INC (LH) stock?

The financial health rating of LABCORP HOLDINGS INC (LH) is 5 / 10.